Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Kiora Pharmaceuticals, Inc. (KPRX) had Operating Cash Flow per Share of $-2.43 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-10.84M |
|
-- |
|
-- |
|
$12.83M |
|
$-12.83M |
|
$0.71M |
|
$-12.12M |
|
$-12.12M |
|
$-10.84M |
|
$-10.84M |
|
$-10.84M |
|
$-10.84M |
|
$-12.83M |
|
$-12.81M |
|
4.17M |
|
4.10M |
|
$-2.60 |
|
$-2.64 |
|
| Balance Sheet Financials | |
$21.75M |
|
$0.09M |
|
$2.50M |
|
$24.25M |
|
$3.63M |
|
-- |
|
$4.50M |
|
$8.13M |
|
$16.13M |
|
$14.06M |
|
$16.13M |
|
3.76M |
|
| Cash Flow Statement Financials | |
$-9.96M |
|
$14.43M |
|
$0.27M |
|
$3.80M |
|
$8.70M |
|
$4.90M |
|
$0.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-67.19% |
|
-77.04% |
|
-44.67% |
|
-67.19% |
|
$4.29 |
|
$-2.45 |
|
|
Operating Cash Flow per Share |
$-2.43 |